IBM Watson Health, Cota Healthcare and Hackensack Meridian Health are partnering to test clinical decision support in cancer treatment, a pilot that will draw on Cota's precision-medicine database and Watson Health's artificial intelligence-enabled evidence-based recommendations.
Read Full Release
Danbury, Conn. (May 18, 2017) — Odyssey Logistics & Technology Corp. (Odyssey), a global leading logistics provider, today announced that it has been positioned by Gartner, Inc. on the “Magic Quadrant for Third Party Logistics Providers, North America” for 2017. This marks the first time Odyssey has been placed on the Gartner Magic Quadrant.
Read Full Release
MassBio Lunch and Learn: Navigating Accelerated Approvals in Today’s Oncology Drug Development Landscape: Ensuring a Properly Tailored Approached Based on FDA Expectations and Current Trends in Drug Development
Read Full Release
Imagine waiting for your diagnosis. The doctor walks in and says, “Well, I just consulted with everyone on the planet Earth over the last 30 years to see how they took care of people like you, and then I looked at a database that precisely looked at people who have exactly what you have, and are exactly like you, and this is what I have learned in the past five minutes, and this is why I am going to recommend this treatment.”
Read Full Release
BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round. The round was led by Debiopharm Innovation Fund in conjunction with Tesi, a Finnish venture capital and private equity company, and was supported by BC Platforms’ existing investors. BC Platforms will use the funds to launch new technologies in 2017 integrating complex clinical and genomic data in order to deliver precision medicine and clinical patient benefits, as well as to grow its existing genomic data management software business worldwide.
Read Full Release
Cota Healthcare, the leading data and technology platform for value-based precision medicine, today announced the signing of a major, multi-year collaboration with Novartis Pharmaceuticals Corporation to help improve clinical and cost outcomes for breast cancer patients.
As part of this agreement, which expands significantly on the previous announced collaboration entered into January 2016, teams from across Novartis Pharmaceuticals Corporation will leverage Cota's research-grade, real-world evidence, web-based analysis and visualization tools, and be supported by Cota's medical, data science, and technology experts. Utilizing the real-world evidence and technology platform supplied by Cota is expected to enable Novartis Pharmaceuticals Corporation to accelerate clinical development of new therapies for breast cancer and identify which patients will benefit most.
Read Full Release
Bivarus, a patient-centered analytics company working with healthcare organizations to measure and analyze the patient experience and employee engagement, announced today it raised $4 million in a Series B from existing investors. Hatteras Venture Partnersled this latest financing round. Other participants in the round include Excelerate Health Ventures, Nashville-based NueCura Partners and Boston Millennia Partners.
Read Full Release
One effect of the Affordable Care Act, a.k.a. Obamacare? A spike in venture interest in health care startups. Digital health care companies raised $2.3 billion in the first half of 2014, which surpasses the total raised in all of 2013, according Rock Health, a health care-focused seed fund. That figure is impressive given that 2013 was already a record year at $1.9 billion raised. (That's a 39% increase year over year, even as biotech investment grew just 8% and medical devices investment fell by 17%.)
Read Full Release
One good piece of news in recent years is that people around the world are living longer. The less good news is that older age exposes more of us to varieties of cognitive decline, including Alzheimer’s disease. According to the Alzheimer’s Association, the number of people with this diagnosis is likely to grow from around five million today to some 13.5 million in 2050. What could help stem this tsunami of pending illness? A team from MIT and Lahey Hospital and Medical Center has created a tool that will make it easier to detect cognitive impairment, enabling treatment to begin earlier and, potentially, improve outcomes.
Read Full Release